Kasha Bornstein, MSc Pharm, EMT-P

Medical school: University of Miami

Ongoing barriers to medication-assisted treatment for opioid use disorder contribute to a major care gap, with only 10% of patients seeking long-term OUD treatment able to receive it. It's time to imp
Naloxone is a potent opioid receptor antagonist with an excellent safety profile and ability to reverse opioid-associated respiratory depression. Is it as effective when you're faced with patients in
Excited delirium syndrome is a common yet poorly characterized ED presentation with a wide differential diagnosis. Patients are often identified initially by law enforcement, but attempts to control i
CHAT NOW
CHAT OFFLINE